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The Sex Bias in TB Cases May Be
of Biological Significance
Tuberculosis (TB) claims over 1.7
million lives throughout the world each
year according to the most recent World
Health Organization (WHO) report [1].
Men seem to be more affected than
women, with a male/female ratio of
1.960.6 for the worldwide case notifica-
tion rate (Box 1; Figure 1) [1]. In some
countries this ratio may reach values as
high as 3 (4.7 in Armenia for instance), but
ratios below 1 are extremely rare and
mostly correspond to very small popula-
tions of patients [1]. This excess of male
pulmonary TB cases is seen in all regions
of the world, and in almost all countries
(Figure 2A), at least in non–HIV-infected
patients. It is also seen in adults of all ages,
but does not seem to apply to children and
young adolescents (Figure 2B).
As case notification is a complicated
process, beginning with the recognition of
initial symptoms and followed by clinical
diagnosis and reporting, this indicator
necessarily combines various factors, in-
cluding, for example, differences in both
susceptibility and exposure, help-seeking
behavior, and access to health care services.
Several reviews have discussed the possibil-
ity of undernotification of women due to
greater difficulties in gaining access to
clinics and in obtaining a timely diagnosis
and treatment, particularly in developing
countries [2]. Other confounding factors,
such as smoking, alcohol and drug use,
exposure to indoor dusts and air pollution,
as well as the poor quality of sputum
samples collected from women in some
regions, may influence the sex bias ob-
served in patients with TB [3–8].
The case notification rate therefore may
not reveal the many facets of inequality
between male and female patients with TB.
However, the poorer access of female
patients to health care does not account
for the higher incidence of detection on the
basis of positive smears in a number of
situations, including low-income countries
[9]. A recent multicentre case-control study
conducted in three West African countries
concluded that male sex is indeed a risk
factor for TB, independent of other factors
examined; in this case multivariate analysis
of environmental and host-related factors
found a male/female ratio of 2.03 among
patients with TB (versus 1.12 in the contact
population, p=0.02) [5].
Unlike studies based on case notifica-
tion, large, systematic prevalence surveys
can provide us with information about
genuine biological differences in suscepti-
bility to TB between men and women, if
indeed there are any. A prime example is
provided by a large prevalence survey
conducted in Bangladesh, in which more
than 260,000 individuals (51% males)
were visited in a house-to-house survey
designed to detect cases of suspected TB,
for possible subsequent confirmation by
smear observation [10]. An excess of cases
in males, with a sex ratio of 3:1 (48 males
and 16 females with confirmed TB), was
observed, even if confounding factors,
such as income, awareness, and stigma
were taken into account [11].
Research in Translation discusses health interven-
tions in the context of translation from basic to
clinical research, or from clinical evidence to
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Summary Points
N In most countries, tuberculosis (TB) notification is twice as high in men as in
women.
N Although there is clear evidence that socioeconomic and cultural factors
leading to barriers in accessing health care may cause undernotification in
women, particularly in developing countries, biological mechanisms may
actually account for a significant part of this difference between male and
female susceptibility to TB.
N The role of biological gender has been determined in a number of infectious
and noninfectious diseases. However, there is an absence of information on the
role of biological gender in TB.
N Thus, investigations should be conducted to clearly understand the role of
sexual hormones, sex-related genetic background and genetic regulations, and
metabolism, among other factors, in susceptibility differences between men
and women.
N This research may help not only to fully understand the obviously biased
gender distribution among TB cases, but also to better adapt future
intervention strategies at the community level. In this review, we expand on
the various issues relating to TB notification and gender bias.
PLoS Medicine | www.plosmedicine.org 1 December 2009 | Volume 6 | Issue 12 | e1000199Leaving aside sociocultural biases, bio-
logical factors leading to differences in
resistance to infection/disease between
men and women may account, at least in
part, for the worldwide excess of male
pulmonary TB cases detected by case
notification and epidemiological surveys.
Surprisingly, this topic has been largely
ignored in scientific and medical investi-
gations, despite the importance of dissect-
ing the biological processes underlying the
observed differences between the sexes to
our understanding of the mechanisms
involved in host susceptibility to TB in
the general population.
The human population as a whole is
actually highly resistant to TB, with ‘‘only’’
5% to 10% of exposed individuals going on
to develop the disease during their lifetime
[12].Many factors, including the virulence of
the infecting strain, and the nutritional status,
hygiene,age, ethnic and genetic background,
immunosuppression status, and, possibly, sex
of the infected host, may account for the
greater susceptibility of individuals develop-
ing the disease than of the remaining healthy
population. However, several other, more
specific biological sex-related factors may
r e n d e rm e ne v e nm o r es u s c e p t i b l et o
pulmonary TB than women: sex steroid
hormones, the genetic makeup of the sex
chromosomes, and sex-specific metabolic
features. These factors are, of course,
interconnected in real life, but for practical
reasons we will review them independently.
Sex Steroids and the
Antimycobacterial Immune
Response
The effects of sex steroid hormones on
the immune response to infection and
other noninfectious immune disorders,
and, more generally, the interplay between
the endocrine and the immune systems,
are widely documented in humans and
animal models [13–16]. Simple experi-
ments in castrated and hormone-reconsti-
tuted animals can reveal the influence of
sex hormones on immune functions. For
example, it has been reported that andro-
gen deprivation due to the castration of
male mice leads to an increase in the
absolute number of T lymphocytes in the
peripheral lymph nodes and an increase in
the proliferation of these cells following
antigen recognition [17].
Other examples are provided by reports
showing that estradiol enhances macro-
phage activation [18], and that invariant
natural killer T (iNKT) cells from female
mice produce more interferon-gamma
(IFNc) than do the cells from male mice
in response to in vivo challenge with the
iNKT cell ligand a-GalCer [19]. Female
castration or genetic ablation of the
estradiol receptor impairs IFNc produc-
tion by these cells, the normal phenotype
being restored by estradiol injection.
These results illustrate the general, but
probably simplistic perception of estradiol
as an immunity-sustaining or immunity-
enhancing mediator, and of testosterone as
a mediator inhibiting the immune re-
sponse [20].
Surprisingly, very few studies have
considered the role of sex steroids in host
protection and susceptibility to TB in
humans or animals. The male gender bias
in TB detection rate may involve sex
hormones as it becomes apparent after
sexual maturity (Figure 2B). This suggests
that sexual hormones may play a part in
protection/susceptibility to TB. The pos-
sible role of sex steroids in TB is also
strengthened by the fact that the progres-
sion-to-disease and mortality rates are
higher in females during their reproduc-
tive years, after which such rates turn
again to be higher in men (reviewed in
[2,21]).
Early reports for other mycobacterial
infections shed some light on this issue.
Female mice are more resistant to infec-
tion with bacteria of two species related to
Mycobacterium tuberculosis: M. intracellulare
and M. marinum [22,23]. The treatment
of females or castrated males with testos-
terone increases their susceptibility to M.
marinum, and it has been suggested that the
higher susceptibility of males to both these
infections may be due to differences
between the sexes in terms of innate
resistance mechanisms mediated by host
phagocytes. The role of estradiol in
mycobacterial infections has also been
investigated in other experimental settings.
Estradiol treatment abolishes the greater
Box 1. Six Key Papers on Sex Bias in TB
N Grossman CJ [13]. A thorough and early review on the links between the
endocrine and the immune systems
N Naugler WE, Sakurai T, Kim S, Maeda S, Kim K, et al. [49]. An in-depth
investigation of the molecular mechanisms through which estrogen inhibits IL-
6 production and protects females from hepatocarcinoma. May inspire similar
research in the TB field
N Yamamoto Y, Tomioka H, Sato K, Saito H, Yamada Y, et al. [23]. The first animal
model-based report on differential susceptibility of males and females to a
mycobacterial infection
N Hamid Salim MA, Declercq E, Van Deun A, Saki KAR [11]. One of the best
examples of a population-wide prevalence survey concluding that there is a
male/female bias in susceptibility to TB
N Borgdorff MW, Nagelkerke NJD, Dye C, Nunn P [10]. A meta-analysis of nearly 30
reports on notifications and prevalence data concluding that male/female ratio
in TB is not due to differential access to health care in most cases
N Fortin A, Abel L, Casanova JL, Gros P [30]. A thorough review on current
knowledge and future perspectives in genetics of mycobacterial infections
Figure 1. Sex distribution for new smear-positive TB case notification in 2007 in
various countries [1].
doi:10.1371/journal.pmed.1000199.g001
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avium, with estradiol again appearing to act
in synergy with IFNc to impair mycobac-
terial growth [24].
Similar results have been obtained for
other intracellular pathogens, such as
Coxiella [25], and the parasite Leishmania.
As for TB, the incidence of visceral
leishmaniasis seems to be higher in males,
and there is experimental evidence to
suggest that the protective Th1 response
associated with IFNc production is stron-
ger in females, at least partly because of
the action of estrogens [26]. This potential
role of estrogens is not surprising, as
estrogen has been shown to increase the
activity of the IFNc gene promoter [27].
Levels of steroid hormones vary not only
between the sexes, but also with age and
physiological state (e.g., menstrual cycles
and gestation). The influence of these
variations of sex hormone levels on
resistance or susceptibility to TB remains
to be investigated.
Is TB Associated with a Sex-
Specific Genetic Architecture?
It is now widely accepted that host
genetic factors play a major role in
determining differential susceptibility to
infection and disease outcome in humans
[28,29]. Most studies in the context of TB
have investigated the role of specific
candidate genes, chosen on the basis of
the effects of their murine orthologs on the
response to experimental mycobacterial
infections or the known biology of the
disease. Despite the fact that the quality of
these studies varies greatly, genetic varia-
tion in an increasing number of genes (e.g.,
NRAMP1, HLA class II, VDR, MAL/
TIRAP, DC-SIGN, MCP-1, TLR8) has been
found to be associated with complex
susceptibility to pulmonary TB (reviewed
in [29,30]).
Unlike candidate-gene studies, in which
the choice of the genes to be tested may be
arbitrary, genome-wide linkage analyses
are more systematic and suitable for the
identification of loci with a substantial
effect on disease phenotype (i.e., major
susceptibility loci). A few genome-wide
linkage analyses have been performed to
date, and the results are not always
consistent among studies. Early studies
provided evidence for linkage on Chro-
mosomes 15q and Xq in African families
[31], and 11q and 20p in Brazilian families
[32]. However, these studies did not
provide evidence for the existence of a
major susceptibility locus. The first major
locus identified by genome-wide linkage
analyses was recently mapped to 8q12-
q13, which houses at least one major gene
that confers predisposition to pulmonary
TB in adults with a dominant mode of
inheritance [33]. The precise genes and
variants within this region actually in-
volved in susceptibility to TB remain to be
identified.
Some of the reported associations re-
main to be confirmed, but we now need to
consider how host genetic variation at
these loci (or other loci yet to be identified)
results in sex-specific differences in TB
incidence. Intuitively, it would seem rea-
sonable to assume that the sex chromo-
somes make some contribution. The first
genome-wide linkage analysis of TB iden-
tified a region on Xq for which there was
suggestive, but not significant, evidence for
linkage to TB [31]. However, this finding
has not been replicated by any other
genome-wide linkage study, and no asso-
ciation between any gene located on Xq
and complex susceptibility to TB has yet
been reported.
A recent association study screening
variation at 18 genes involved in the Toll-
like receptor (TLR) pathway identified four
polymorphisms in the TLR8 gene, which is
located on chromosome X (Xp22), which
seemed to be associated with complex
susceptibility to pulmonary TB in an
Indonesian cohort [34]. All four of these
polymorphisms are in perfect linkage
disequilibrium, and one (rs3764880) is a
missense variant (Val1Met) that could
indeed be the functional polymorphism
associated with the disease. When perform-
ingthetestsseparatelyformen andwomen,
the authors observed a strong association
between the rs3764880 allele A (Met) and
susceptibility to TB that was restricted to
men.
This association was subsequently repli-
cated in a large, independent cohort from
Russia, suggesting that there may be a
genuine effect. The frequency of the
‘‘susceptibility’’ allele (rs3764880 allele A)
is very different in the Indonesian (,30%)
and Russian (,80%) populations. This
observation suggests that the relative effect
of this allele on susceptibility to TB may
differ in the two populations, owing to
differences in TB exposure, the virulence of
the bacteria, and differences in the genetic
make-up of the two human populations, for
example. The association observed be-
tween X-linked variation at the TLR8 gene
locus and complex susceptibility to TB is
consistent with sex-specific effects on the
genetic architecture of TB [34].
Indirect evidence for a possible role of the
X chromosome in susceptibility to TB has
also been provided by studies of Mendelian
susceptibility to mycobacterial diseases
(MSMD). Causal mutations in an X-linked
gene (NEMO) and in two candidate regions
on Xp11.4–Xp21.2 and Xq25–Xq26.3
have been identified in patients suffering
from MSMD, some of whom also have
presented TB [35,36]. These studies suggest
that variation in the X chromosome may be
involved in the genetic predisposition to TB,
from both Mendelian and complex genetic
perspectives [30].
Figure 2. Regional (A) and age (B) distribution of the male/female ratio for new smear-
positive TB cases in 2007. (A) Dot-plot in which each dot corresponds to a country. EUR,
Europe; SEAR, Southeast Asia; WPR, Western Pacific; AMR, the Americas; AFR, Africa. The bar
indicates the mean. (B) Box plot showing the 25th and 75th percentiles, together with the
median, with whiskers showing the minimum and maximum male/female ratio for new smear-
positive TB cases in 2007 in the Americas. Crosses indicate means. Data were compared with the
male/female ratio expected under the hypothesis of neutrality (1, red line) and were analyzed
with Mann-Whitney tests (***, p,0.0001) [1]. NS, not significant.
doi:10.1371/journal.pmed.1000199.g002
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better appreciation of the extent to which
sex-specific genetic effects lead to differenc-
es in the prevalence of TB between men
and women requires further large-scale
genetic studies, involving large cohorts of
clinically well-defined TB cases and appro-
priate controls, stratified by sex. In partic-
ular, sex-specific genetic effects may not be
restricted to the obvious case of sex
chromosomes. Autosomal DNA sequences
do not differ between men and women, but
differences in gene regulation between the
sexes have been documented (reviewed in
[37]). Thus, studies on sex-specific differ-
ences in gene regulation in the context of
TB should help to delineate the basis of the
phenotypic sexual dimorphism observed
for susceptibility to this major disease.
Sex, Nutrition, and TB
Sex-specific features of nutrition and
metabolism may also be associated with
susceptibility or resistance to M. tuberculosis.
Iron, for instance, is a crucial component
of several enzymes and redox systems in
mycobacteria, as in all living organisms.
The extrusion of iron from the microbial
vacuole has long been recognized as an
innate immune system mechanism, con-
served throughout evolution, for host
phagocyte control of various intracellular
pathogens, including mycobacteria [38].
Iron deficiency is common in women from
developing and industrialized countries
[39]. It remains unclear whether anemia
is correlated with greater resistance to TB
in humans. However, experimental evi-
dence from animals suggests that iron
overload increases permissiveness to M.
tuberculosis considerably, both in vivo [40]
and in vitro [41].
Major differences have also been found
between the sexes in terms of fat metab-
olism. These differences may influence
susceptibility to infectious disease, and to
TB in particular [42]. Other nutrients and
cofactors, such as vitamin D [43,44], play
an important role in antimycobacterial
immunity, and their possible role in sex-
related aspects of the immune response to
M. tuberculosis remains to be established.
Again, the effect of nutrients and nutri-
tional status on differential susceptibility to
TB may rely on sex hormones, as recently
exemplified by the estrogen/vitamin D
synergy in resistance to experimental
autoimmune encephalomyelitis [45].
Finally, other yet unsuspected gender-
related features may render men more
susceptible to M. tuberculosis than women.
For instance, it is well known that men and
women present important differences in
the anatomy and physiology of the upper
airway and respiratory tract [46]. These
differences include structural and func-
tional differences (e.g. oropharyngeal
length and ventilatory functions) as well
as histological differences (e.g., the amount
and distribution of the fat around the
pharynx and along the upper airway).
Some of these features are indeed influ-
enced by sex steroids and aging, and
whether they play a part in differential
susceptibility to airborne infections, in-
cluding TB, has yet to be evaluated.
Conclusion
Large prevalence surveys have suggest-
ed that the sex bias observed in pulmonary
TB cases may result partly from genuine
biological differences in male and female
susceptibility to M. tuberculosis infection or
the development of TB disease. This
finding would not be particularly surpris-
ing, as many studies in humans and
experimentally infected animals have es-
tablished clear links between sex-specific
factors, including steroid hormones and
genetic variants, and the differential sus-
ceptibility of males and females to a
number of other infectious and noninfec-
tious diseases. In particular, gender bias
among pulmonary microbial diseases is
not restricted to TB, and important sex
differences in the incidence and severity of
a number of respiratory tract bacterial
infections have been reported in the
literature [47]. As a selected example, it
has been shown that men have a 4-times
higher risk of developing nosocomial
Legionella pneumophila infection than women
[48].
Only 5% to 10% of individuals exposed
to M. tuberculosis develop TB, and up to
70% of those who do develop the disease
are male. In other words, the human
population as a whole is remarkably
resistant to M. tuberculosis, but women
seem to be even more resistant to the
bacillus than men. So, why do only a
minority of individuals, other than patients
with HIV/AIDS, fail to control infection?
Why are women less likely to develop TB
than men? Why are some women more
resistant to TB than other women exposed
to a similar extent? Field research consor-
tia including not only microbiologists,
immunologists, and human geneticists,
but also epidemiologists and sociologists,
should be established to unravel the many
faces of sexual inequality in TB, and to
decipher the delicate mechanisms involved
in natural and sex-associated resistance to
TB (Box 2; Figure 3). Such work would
facilitate the design of future intervention
Box 2. Key Research Actions on Sex Bias in TB
N Parallel and homogeneous epidemiological surveys in human populations from
different geographic and ethnic backgrounds to dissect simultaneously the
various factors possibly contributing to the sex bias in TB in the most
exhaustive manner, including:
# Sociocultural components: income, stigmatization, awareness, etc.
# Behavioural components: smoking, alcohol and drug abuse, exposure to toxic
dusts at the work place, dietary differences, etc.
# Biological components: sex hormones, genetic background
N Detailed follow-ups of sex hormone profiles in men and women presenting TB,
as well as in the corresponding healthy contacts exposed to the same
environmental pressures
N Development of an appropriate animal model that mimics the sex bias
observed in TB in humans for subsequent in vivo dissection of the influence of
sex hormones in castrated and hormone-reconstituted animals on immune
response to M. tuberculosis and disease outcome
N Development of suitable in vitro cell models to investigate the influence of sex
hormones and immune modulators (cytokines and nutrients such as iron,
vitamin D, etc.) on the immune response to M. tuberculosis (see Figure 3)
N Genome-wide association studies in populations from diverse geographic areas,
involving large cohorts of clinically well-defined TB cases and appropriate
controls, stratified by sex
N Genome-wide gene expression profiling in different in vitro and ex vivo
biological settings (e.g., monocyte-derived phagocytes, blood samples, lung
biopsies, broncho-alveolar lavages) from male and female TB patients and
relevant controls
PLoS Medicine | www.plosmedicine.org 4 December 2009 | Volume 6 | Issue 12 | e1000199strategies for combating the disease and
the development of useful tools for evalu-
ating prognosis and protection in future
clinical trials.
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